tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Simcere Pharmaceutical Announces Share Placing and Subscription Agreement

Story Highlights
Simcere Pharmaceutical Announces Share Placing and Subscription Agreement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Simcere Pharmaceutical Group Limited ( (HK:2096) ) has shared an update.

Simcere Pharmaceutical Group Limited announced a placing and top-up subscription agreement involving the sale of 121,000,000 existing shares and the issuance of an equivalent number of new shares under a general mandate. The transaction, coordinated by Morgan Stanley Asia Limited, is set at a placing price of HK$12.95 per share, representing a discount to recent trading prices. The gross proceeds are estimated at approximately HK$1,567.0 million, with net proceeds intended for specific applications. This strategic move aims to strengthen the company’s financial position and enhance its market presence, although it remains subject to certain conditions and may not proceed to completion.

More about Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. The company focuses on the development, production, and sale of pharmaceutical products.

Average Trading Volume: 21,755,235

Technical Sentiment Signal: Buy

Current Market Cap: HK$34.94B

For detailed information about 2096 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1